Table of Contents

    Topic review

    Complement Factor I Deficiency

    Subjects: Genetics
    View times: 4
    Submitted by: Nicole Yin
    (This entry belongs to Entry Collection "MedlinePlus ")

    Definition

    Complement factor I deficiency is a disorder that affects the immune system. People with this condition are prone to recurrent infections, including infections of the upper respiratory tract, ears, skin, and urinary tract. They may also contract more serious infections such as pneumonia, meningitis, and sepsis, which may be life-threatening.

    1. Introduction

    Some people with complement factor I deficiency have a kidney disorder called glomerulonephritis with isolated C3 deposits. Complement factor I deficiency can also be associated with autoimmune disorders such as rheumatoid arthritis or systemic lupus erythematosus (SLE). Autoimmune disorders occur when the immune system malfunctions and attacks the body's tissues and organs.

    2. Frequency

    Complement factor I deficiency is a rare disorder; its exact prevalence is unknown. At least 38 cases have been reported in the medical literature.

    3. Causes

    Complement factor I deficiency is caused by mutations in the CFI gene. This gene provides instructions for making a protein called complement factor I. This protein helps regulate a part of the body's immune response known as the complement system. The complement system is a group of proteins that work together to destroy foreign invaders (such as bacteria and viruses), trigger inflammation, and remove debris from cells and tissues. This system must be carefully regulated so it targets only unwanted materials and does not attack the body's healthy cells. Complement factor I and several related proteins protect healthy cells by preventing activation of the complement system when it is not needed.

    Mutations in the CFI gene that cause complement factor I deficiency result in abnormal, nonfunctional, or absent complement factor I. The lack (deficiency) of functional complement factor I protein allows uncontrolled activation of the complement system. The unregulated activity of the complement system decreases blood levels of another complement protein called C3, reducing the immune system's ability to fight infections. In addition, the immune system may malfunction and attack its own tissues, resulting in autoimmune disorders.

    5. Inheritance

    This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

    6. Other Names for This Condition

    • C3 inactivator deficiency
    • complement component 3 inactivator deficiency
    • hereditary factor I deficiency disease

    The entry is from https://medlineplus.gov/genetics/condition/complement-factor-i-deficiency

    References

    1. Baracho GV, Nudelman V, Isaac L. Molecular characterization of homozygoushereditary factor I deficiency. Clin Exp Immunol. 2003 Feb;131(2):280-6.
    2. Grumach AS, Leitão MF, Arruk VG, Kirschfink M, Condino-Neto A. Recurrentinfections in partial complement factor I deficiency: evaluation of threegenerations of a Brazilian family. Clin Exp Immunol. 2006 Feb;143(2):297-304.
    3. Nilsson SC, Trouw LA, Renault N, Miteva MA, Genel F, Zelazko M, Marquart H,Muller K, Sjöholm AG, Truedsson L, Villoutreix BO, Blom AM. Genetic, molecularand functional analyses of complement factor I deficiency. Eur J Immunol. 2009Jan;39(1):310-23. doi: 10.1002/eji.200838702.
    4. Pettigrew HD, Teuber SS, Gershwin ME. Clinical significance of complementdeficiencies. Ann N Y Acad Sci. 2009 Sep;1173:108-23. doi:10.1111/j.1749-6632.2009.04633.x. Review.
    5. Ponce-Castro IM, González-Rubio C, Delgado-Cerviño EM, Abarrategui-Garrido C, Fontán G, Sánchez-Corral P, López-Trascasa M. Molecular characterization ofComplement Factor I deficiency in two Spanish families. Mol Immunol. 2008May;45(10):2764-71. doi: 10.1016/j.molimm.2008.02.008.
    6. Vyse TJ, Morley BJ, Bartok I, Theodoridis EL, Davies KA, Webster AD, WalportMJ. The molecular basis of hereditary complement factor I deficiency. J ClinInvest. 1996 Feb 15;97(4):925-33.
    7. Vyse TJ, Späth PJ, Davies KA, Morley BJ, Philippe P, Athanassiou P, Giles CM, Walport MJ. Hereditary complement factor I deficiency. QJM. 1994Jul;87(7):385-401. Review.
    More